Linagliptin for elderly patients with type 2 diabetes.
Université Bordeaux Segalen, Bordeaux 33076, France. Electronic address: francesco.salvo@u-bordeaux2.fr.
Francesco
F
Salvo
Université Bordeaux Segalen, Bordeaux 33076, France.
Nicholas
N
Moore
Université Bordeaux Segalen, Bordeaux 33076, France.
Antoine
A
Pariente
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D011687:Purines / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D011687:Purines; D011799:Quinazolines